Follow The Filings

NMRA position history

The shares of Neumora Therapeutics (NMRA) that DAFNA Capital Management LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q1: 70,000 shares, $137K, 0.03% of portfolio, New
  2. 2026 Q2: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders